Home | Welcome to Contract Pharma   
Last Updated Sunday, October 26 2014
Print

Search Results for 'Financial Report: Thermo Fisher Scientific'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published June 5, 2014
Will share R&D rights to gene editing technology Read More »
Published September 4, 2013
Extends long-standing relationship Read More »
Published January 31, 2013
Revenues up 6% in the quarter Read More »
Published July 16, 2012
Will become part of Thermo’s Specialty Diagnostics Segment Read More »
Published January 6, 2012
Combines product and lab support services for customers Read More »
Published February 2, 2011
Acquisitions help with revenue growth Read More »
Newsmakers: Lilly & Fisher Clinical Services
By Gil Y. Roth
Published May 10, 2010
Clinical materials alliance advances Lilly’s FIPNet strategy Read More »
Published September 15, 2009
Marc N. Casper has been appointed president, chief executive officer and a director of Thermo Fisher Scientific Inc., effective October 15, 2009. Read More »
Published October 12, 2007
Thermo Fisher Scientific, Inc. has plans to construct an $11 million, state-of-the-art BioCenter for the manufacture of single-use bioprocess containers (BPCs) and related products at its existing bioprocess production unit in Logan, UT. The inv… Read More »
Published December 15, 2006
Thermo Fisher Scientific, Inc. has acquired Cohesive Technologies, Inc., adding in-line sample preparation capabilities that couple with mass spectrometry technology to create end-to-end workflow solutions for drug and other organic molecule analyses… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On